PSILOCYBIN: 48 Adverse Event Reports & Safety Profile
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
48
Total FAERS Reports
1 (2.1%)
Deaths Reported
16
Hospitalizations
48
As Primary/Secondary Suspect
1
Life-Threatening
1
Disabilities
First Report: 20070101 · Latest Report: 20250125
What Are the Most Common PSILOCYBIN Side Effects?
#1 Most Reported
Drug diversion
20 reports (41.7%)
#2 Most Reported
Drug abuse
11 reports (22.9%)
#3 Most Reported
Drug interaction
10 reports (20.8%)
All PSILOCYBIN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug diversion | 20 | 41.7% | 0 | 1 |
| Drug abuse | 11 | 22.9% | 1 | 2 |
| Drug interaction | 10 | 20.8% | 0 | 10 |
| Drug ineffective | 9 | 18.8% | 0 | 1 |
| Headache | 9 | 18.8% | 0 | 1 |
| Fatigue | 8 | 16.7% | 0 | 0 |
| Serotonin syndrome | 8 | 16.7% | 0 | 8 |
| Dizziness | 7 | 14.6% | 0 | 0 |
| Myalgia | 7 | 14.6% | 0 | 0 |
| Acute coronary syndrome | 5 | 10.4% | 0 | 5 |
| Homicide | 5 | 10.4% | 0 | 1 |
| Hypertensive emergency | 5 | 10.4% | 0 | 5 |
Who Reports PSILOCYBIN Side Effects? Age & Gender Data
Gender: 29.2% female, 70.8% male. Average age: 39.1 years. Most reports from: US. View detailed demographics →
Is PSILOCYBIN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2007 | 1 | 0 | 0 |
| 2021 | 3 | 1 | 0 |
| 2022 | 2 | 0 | 2 |
| 2025 | 1 | 0 | 0 |
What Is PSILOCYBIN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 32 |
| Depression | 11 |
Official FDA Label for PSILOCYBIN
Official prescribing information from the FDA-approved drug label.